Premier Alternatives

Valink Therapeutics

Drug Discovery · London, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a modular protein platform designed to facilitate the scalable discovery of bi-specific biologics. Valink Therapeutics is based in London, United Kingdom and was founded in 2020. It was valued at $12.6 million at its seed round in Nov 2023, the last priced event on record. It has raised $20.5 million across 1 recorded round; the latest was a $7.6 million seed round in Nov 2023.

PMV mark · valuation
$12.6M
Oct 2026
Priced at
its seed round
Nov 2023
Total raised
$20.5M
Last round
Seed Round
Nov 2023

Valink Therapeutics key facts

as of Oct 2026
  • Developer of a modular protein platform designed to facilitate the scalable discovery of bi-specific biologics.
  • Valink Therapeutics is valued at approximately $12.6M as of Oct 2026, set at its seed round, Nov 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $20.5M across 1 recorded rounds; the latest was Seed Round ($7.6M) in Nov 2023.
  • Notable investors include Y Combinator, Creative Destruction Lab, Metaplanet Holdings, Acequia Capital, University of Oxford — 18 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$12.6M

Valued at $12.6M at its seed round, Nov 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Valink Therapeutics with a free account
  • ·The complete investor list: 18 names
  • ·Watch Valink Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valink Therapeutics funding rounds

1 rounds
Nov 2023Seed Round$7.6M▮
Full funding history →

Valink Therapeutics valuation

Valink Therapeutics was valued at $12.6 million at its seed round in Nov 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Valink Therapeutics raised?

Valink Therapeutics has raised $20.5 million in total; 1 of its rounds is on record. The largest on record was a $7.6 million seed round in Nov 2023.

Valink Therapeutics investors

18 investors are on record for Valink Therapeutics, including Y Combinator, Creative Destruction Lab, Metaplanet Holdings and Acequia Capital. The seed round in Nov 2023 drew 8 investors.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Ancilia Bio ($28 million), PAhR Therapeutics ($25 million) and Coding Bio ($6.6 million).

About Valink Therapeutics

Developer of a modular protein platform designed to facilitate the scalable discovery of bi-specific biologics. The company's platform uses robotic screening and big data analysis to discover bispecific lead assets with new modes of action to construct complex bispecific and multispecific biologics and deploys a scalable pipeline for internal and collaborative discovery of bispecific antibodies, from protein design to robotic screening and AI analysis, enabling medical practitioners to provide new alternatives to cancer treatment.

Industry
Drug Discovery
Sector
Healthcare
HQ
London, United Kingdom
Founded
2020
Employees
16
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.